Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera-Reference-Cited by-同舟云学术

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera

Published:2022-08 Issue: Volume:82 Page:104203
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Espeseth Amy S.,Yuan Maoli,Citron Michael,Reiserova Lucia,Morrow Gavin,Wilson Aaron,Horton Melanie,Rukhman Mark,Kinek Keith,Hou Fuxiang,Li Shui L.,Li Fengsheng,Choi Yesle,Heidecker Gwen,Luo Bin,Wu Guoxin,Zhang Lan,Strable Erica,DeStefano Joanne,Secore Susan,Mukhopadhyay Tarit K.,Richardson Douglas D.,Sayeed Eddy,Welch Lisa S.,Bett Andrew J.,Feinberg Mark B.,Gupta Swati B.,Cooper Christopher L.,Parks Christopher L.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference104 articles.

1. The variant gambit: COVID-19′s next move;Plante;Cell Host Microbe,2021

2. SARS-CoV-2 one year on: evidence for ongoing viral adaptation;Peacock;J Gen Virol,2021

3. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic;Boni;Nat Microbiol,2020

4. Coronavirus membrane fusion mechanism offers a potential target for antiviral development;Tang;Antivir Res,2020

5. Immunity to SARS-CoV-2 induced by infection or vaccination;Castro Dopico;J Intern Med,2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview;Heliyon;2024-08

2. Innovative translational platforms for rapid developing clinical vaccines against COVID‐19 and other infectious disease;Biotechnology Journal;2024-02

3. Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective;ACS Biomaterials Science & Engineering;2023-12-14

4. Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both;Scientific Reports;2023-12-04

5. Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSVMT) in golden syrian hamster;Acta Pharmaceutica Sinica B;2023-12